Parkside Financial Bank & Trust Has $264,000 Stock Position in CorVel Corp. $CRVL

Parkside Financial Bank & Trust increased its holdings in shares of CorVel Corp. (NASDAQ:CRVL) by 8,769.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,572 shares of the business services provider’s stock after buying an additional 2,543 shares during the quarter. Parkside Financial Bank & Trust’s holdings in CorVel were worth $264,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Meeder Asset Management Inc. bought a new stake in shares of CorVel in the first quarter worth about $25,000. Hantz Financial Services Inc. acquired a new position in shares of CorVel in the 2nd quarter valued at approximately $32,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in shares of CorVel in the 2nd quarter valued at approximately $37,000. Blue Trust Inc. increased its stake in CorVel by 235.4% during the 2nd quarter. Blue Trust Inc. now owns 550 shares of the business services provider’s stock worth $57,000 after purchasing an additional 386 shares in the last quarter. Finally, Allworth Financial LP raised its holdings in CorVel by 4,000.0% during the 1st quarter. Allworth Financial LP now owns 574 shares of the business services provider’s stock worth $64,000 after buying an additional 560 shares during the period. 51.36% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of CorVel in a report on Tuesday, October 14th. Wall Street Zen cut shares of CorVel from a “buy” rating to a “hold” rating in a research report on Saturday. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, CorVel presently has a consensus rating of “Hold”.

Insider Transactions at CorVel

In related news, CFO Brandon O’brien sold 1,764 shares of the company’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $91.54, for a total transaction of $161,476.56. Following the sale, the chief financial officer owned 8,948 shares in the company, valued at approximately $819,099.92. This represents a 16.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Maxim Shishin sold 12,000 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $89.16, for a total value of $1,069,920.00. Following the transaction, the insider directly owned 7,050 shares of the company’s stock, valued at $628,578. This trade represents a 62.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 44.56% of the company’s stock.

CorVel Stock Up 0.8%

Shares of CRVL opened at $75.97 on Monday. CorVel Corp. has a twelve month low of $70.47 and a twelve month high of $128.61. The stock has a market capitalization of $3.90 billion, a P/E ratio of 39.16 and a beta of 0.98. The company has a 50 day moving average of $78.01 and a 200-day moving average of $92.97.

CorVel (NASDAQ:CRVL) last announced its earnings results on Tuesday, November 4th. The business services provider reported $0.54 EPS for the quarter. The business had revenue of $239.64 million during the quarter. CorVel had a net margin of 10.98% and a return on equity of 32.31%.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.